Ciqtek builds magnetic resonance spectrometers and X-ray diffraction instruments on a quantum precision measurement core, selling enhanced sensors and analytical equipment to enterprises, governments and research institutions. It originated from the University of Science and Technology of China and makes advanced tools for researchers examining the microscopic world, including the EPR200-Plus X-band continuous-wave electron paramagnetic resonance spectrometer and the Xvero-5200 high-speed in-situ two-dimensional X-ray diffractometer series.
It serves customers in quantum technology, materials science, chemistry and chemical engineering, biomedicine, industrial applications, science education and energy exploration. The company develops in-house pulse generators with 50-picosecond timing precision and high-precision arbitrary waveform generators for low-noise, fast quantum coherence control, while its scanning diamond probe delivers non-invasive magnetic imaging with high spatial resolution and sensitivity over wide temperature ranges and large magnetic fields.
Quick Facts
When was Ciqtek's last funding round?
Ciqtek's most recent funding round was for CN¥849M (CNY) in August 2026.
How much disclosed funding has Ciqtek raised?
As of Aug 11, 2026, Ciqtek has disclosed funding of $125.9M (USD).
EPR200M is a compact benchtop electron paramagnetic resonance spectrometer that detects free radicals, transition metal ions, and paramagnetic defects.